![AIS002:055 [Saurabh Jain] Trialkey's World First Clinical Trial Simulator](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://ep-app.cdn.evolvepreneur.net/uploads/media/share_image/0001/05/thumb_4422_share_image_extra_large.jpeg)
AIS002:055 [Saurabh Jain] Trialkey's World First Clinical Trial Simulator
•July 10, 2024
Why It Matters
He also highlights broader AI applications across industries and urges entrepreneurs to embrace AI as a transformative, foundational technology.
Summary
The post discusses Opyl’s AI‑driven clinical trial simulator, which analyzes over 360,000 past trials and 700+ variables to predict trial success with about 90% accuracy and optimize design choices such as patient enrollment. Executive Chair Saurabh Jain argues that this technology could soon make it unethical to run human trials without AI simulation, dramatically boosting drug‑development efficiency. He also highlights broader AI applications across industries and urges entrepreneurs to embrace AI as a transformative, foundational technology.
Comments
Want to join the conversation?
Loading comments...